Literature DB >> 1634615

Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage.

C Baylis1, B Mitruka, A Deng.   

Abstract

Tonic basal release of nitric oxide (NO) by vascular endothelial cells controls blood pressure (BP) in the basal state. In these studies we investigated the effects of chronic inhibition of basal NO synthesis in the rat for a 2-mo period. Significant systemic hypertension developed in chronically NO-blocked rats compared to controls. Marked renal vasoconstriction was also observed with elevations in glomerular blood pressure (PGC) and reductions in the glomerular capillary ultrafiltration coefficient (Kf). Chronically NO-blocked rats also develop proteinuria and glomerular sclerotic injury compared to controls. These studies therefore describe a new model of systemic hypertension with glomerular capillary hypertension and renal disease due to chronic blockade of endogenous NO synthesis. These observations highlight the importance of the endogenous NO system in control of normal vascular tone and suggest that hypertensive states may result from relative NO deficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634615      PMCID: PMC443093          DOI: 10.1172/JCI115849

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex.

Authors:  C Baylis; W M Deen; B D Myers; B M Brenner
Journal:  Am J Physiol       Date:  1976-04

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney.

Authors:  C Baylis; P Harton; K Engels
Journal:  J Am Soc Nephrol       Date:  1990-12       Impact factor: 10.121

5.  NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

Authors:  K Aisaka; S S Gross; O W Griffith; R Levi
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

6.  Control of regional blood flow by endothelium-derived nitric oxide.

Authors:  S M Gardiner; A M Compton; T Bennett; R M Palmer; S Moncada
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

7.  L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats.

Authors:  P Y Chen; P W Sanders
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

9.  Effects of acute nitric oxide inhibition on rat glomerular microcirculation.

Authors:  R Zatz; G de Nucci
Journal:  Am J Physiol       Date:  1991-08

10.  Role of endothelium-derived nitric oxide in the regulation of blood pressure.

Authors:  D D Rees; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more
  108 in total

1.  Basal and stimulated nitric oxide in control of kidney function in the aging rat.

Authors:  C Hill; A M Lateef; K Engels; L Samsell; C Baylis
Journal:  Am J Physiol       Date:  1997-06

2.  Nitric oxide activity in childhood hypertension.

Authors:  C D Goonasekera; V Shah; D D Rees; M J Dillon
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

3.  Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers.

Authors:  Karen Griffin; Aaron Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Geoffrey Williamson; Anil Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

4.  Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.

Authors:  M Hropot; K H Langer; Gabriele Wiemer; H Grötsch; W Linz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-25       Impact factor: 3.000

Review 5.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

6.  NF-κB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase.

Authors:  Suji Kim; Kyu-Sun Lee; Seunghwan Choi; Joohwan Kim; Dong-Keon Lee; Minsik Park; Wonjin Park; Tae-Hoon Kim; Jong Yun Hwang; Moo-Ho Won; Hansoo Lee; Sungwoo Ryoo; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  J Biol Chem       Date:  2018-10-02       Impact factor: 5.157

7.  Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle.

Authors:  Iman Momken; Dominique Fortin; Bernard Serrurier; Xavier Bigard; Renée Ventura-Clapier; Vladimir Veksler
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

8.  Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence.

Authors:  Amanda E Boe; Mesut Eren; Sheila B Murphy; Christine E Kamide; Atsuhiko Ichimura; David Terry; Danielle McAnally; Layton H Smith; Toshio Miyata; Douglas E Vaughan
Journal:  Circulation       Date:  2013-10-03       Impact factor: 29.690

9.  Intrarenal haemodynamic and glomerular responses to inhibition of nitric oxide formation in rabbits.

Authors:  K M Denton; W P Anderson
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

10.  Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.

Authors:  C E Bryant; G H Allcock; T D Warner
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.